David Carruthers

Dr. David Carruthers

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 February 2021 in Science Advances
Verified
Journal Article
Open access
PDF file
TSTatyana E. Saleski
Tatyana E. Saleski
MCMeng Ting Chung
Meng Ting Chung
DCDavid Carruthers
David Carruthers
AKAzzaya Khasbaatar
Azzaya Khasbaatar
Katsuo KurabayashiKatsuo Kurabayashi
Katsuo Kurabayashi
XLXiaoxia Nina Lin
Xiaoxia Nina Lin
Chromosomal integration of recombinant genes is desirable compared with expression from plasmids due to increased stability, reduced cell-to-cell variability, and elimination of the need for antibiotics for plasmid maintenance. Here, we present a new approach for tuning pathway gene expression levels via random integration and high-throughput screening. We demonstrate multiplexed gene integration and expression-level optimization for isobutanol production in Escherichia coli. The integrated strains could, with far lower expression levels than plasmid-based expression, produce high titers (10.0 ± 0.9 g/liter isobutanol in 48 hours) and yields (69% of the theoretical maximum). Close examination of pathway expression in the top-performing, as well as other isolates, reveals the complexity of cellular metabolism and regulation, underscoring the need for precise optimization while integrating pathway genes into the chromosome. We expect this method for pathway integration and optimization can be readily extended to a wide range of pathways and chassis to create robust and efficient production strains.

1 January 2017 in Integrative Biology
Verified
Journal Article
Open access
PDF file
DCDavid Carruthers
David Carruthers
CBChang Kyu Byun
Chang Kyu Byun
BCBradley J. Cardinale
Bradley J. Cardinale
XLXiaoxia Nina Lin
Xiaoxia Nina Lin
A microfluidic platform for rapid, high-throughput screening of algal mixed cultures demonstrating successful elucidation of beneficial transgressive overyielding relationships.

25 November 2020 in ACS Synthetic Biology
Verified
Journal Article
Closed access
DCDavid Carruthers
David Carruthers
TSTatyana E. Saleski
Tatyana E. Saleski
SSScott A. Scholz
Scott A. Scholz
XLXiaoxia Nina Lin
Xiaoxia Nina Lin

22 July 2025 in Bioengineering
Verified
Journal Article
Open access
PDF file
WGWilliam Gaillard
William Gaillard
JSJess Sustarich
Jess Sustarich
YLYuerong Li
Yuerong Li
DCDavid Carruthers
David Carruthers
KGKshitiz Gupta
Kshitiz Gupta
ASAnup K Singh
Anup K Singh
Electroporation-mediated gene delivery is a cornerstone of synthetic biology, offering several advantages over other methods: higher efficiencies, broader applicability, and simpler sample preparation. Yet, electroporation protocols are often challenging to integrate into highly multiplexed workflows, owing to limitations in their scalability and tunability. These challenges ultimately increase the time and cost per transformation. As a result, rapidly screening genetic libraries, exploring combinatorial designs, or optimizing electroporation parameters requires extensive iterations, consuming large quantities of expensive custom-made DNA and cell lines or primary cells. To address these limitations, we have developed a High-Throughput Microfluidic Electroporation (HTME) platform that includes a 384-well electroporation plate (E-Plate) and control electronics capable of rapidly electroporating all wells in under a minute with individual control of each well. Fabricated using scalable and cost-effective printed-circuit-board (PCB) technology, the E-Plate significantly reduces consumable costs and reagent consumption by operating on nano to microliter volumes. Furthermore, individually addressable wells facilitate rapid exploration of large sets of experimental conditions to optimize electroporation for different cell types and plasmid concentrations/types. Use of the standard 384-well footprint makes the platform easily integrable into automated workflows, thereby enabling end-to-end automation. We demonstrate transformation of E. coli with pUC19 to validate the HTME’s core functionality, achieving at least a single colony forming unit in more than 99% of wells and confirming the platform’s ability to rapidly perform hundreds of electroporations with customizable conditions. This work highlights the HTME’s potential to significantly accelerate synthetic biology Design-Build-Test-Learn (DBTL) cycles by mitigating the transformation/transfection bottleneck.

3 September 2026
Verified
Preprint
Open access
PDF file
YCYan Chen
Yan Chen
DCDavid Carruthers
David Carruthers
BSBlake Simmons
Blake Simmons
TLTaek Soon Lee
Taek Soon Lee
CPChristopher Petzold
Christopher Petzold
This protocol details steps in high-throughput measurement of isoprenol (IP) with the Agilent RapidFire 400 coupled with Agilent 6460 QqQ system, and subsequent data processing using the Agilent Quantitative analysis software. This protocol is validated on M9 culture broth and is conditional for additional sample types, such as other microbial fermentation cultures, chemical overlays, intracellular cell lysate, etc. The analytical assay developed under this protocol provides accurate and flexible options for quantifying a small number of samples or high-throughput screening of thousands of samples per day.